AJ Schilz

FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells

Markus Hildinger, H-G Eckert, AJ Schilz et al. · Gene Therapy · 1998 · 47 citations

Life Sciences, Hematology, Molecular Biology +11

Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells

R Knipper, Klaus Kuehlcke, Bernhard Schiedlmeier et al. · Gene Therapy · 2001 · 38 citations

Life Sciences, Molecular Biology, Oncology +14

MDR1 Gene Expression in NOD/SCID Repopulating Cells after Retroviral Gene Transfer under Clinically Relevant Conditions

AJ Schilz, Bernhard Schiedlmeier, Klaus Kühlcke et al. · Molecular Therapy · 2000 · 35 citations · Full text

Pharmacy, Translational Sciences, Cell Therapy +13

Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking

Markus Hildinger, AJ Schilz, H-G Eckert et al. · Gene Therapy · 1999 · 28 citations

Life Sciences, Cell Biology, Immunology +9

Clinical scale production of an improved retroviral vector expressing the human multidrug resistance 1 gene (MDR1)

H-G Eckert, Klaus Kühlcke, AJ Schilz et al. · Bone Marrow Transplantation · 2000 · 27 citations

Life Sciences, Pharmaceutical Biotechnology, Pharmaceutics +12